Evidence map›Paper›PMID 26014927›Full record

ArticleAntimicrobial agents and chemotherapy2015

First Report of OXA-181-Producing Escherichia coli in China and Characterization of the Isolate Using Whole-Genome Sequencing.

Yanbin Liu, Yu Feng, Wenjing Wu, Yi Xie, Xiaohui Wang, Xiaoxia Zhang, Xinchuan Chen, Zhiyong Zong

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 107 citations in OpenAlex.

  1. Review
  2. Genomic landscape ofApplied and environmental microbiology · 2026
    Article
  3. Article
  4. Review
  5. OXA-48-like carbapenemases inEmerging microbes & infections · 2024
    Article
  6. Emergence of blaBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  7. Article
  8. First report ofMicrobiology spectrum · 2024
    Article
  9. Antimicrobial agents and chemotherapy · 2024
    Review
  10. Article
  11. First Report of OXA-181-ProducingMicrobiology spectrum · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The First Report ofInfection and drug resistance · 2023
    Article
  17. Review
  18. Article
  19. Characterization of the First Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yanbin LiuCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China Division of Infectious Diseases, State Key Laboratory of Biotherapy, Chengdu, China.
Yu FengCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China Division of Infectious Diseases, State Key Laboratory of Biotherapy, Chengdu, China.
Wenjing WuCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China Division of Infectious Diseases, State Key Laboratory of Biotherapy, Chengdu, China.
Yi XieLaboratory of Clinical Microbiology, Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Xiaohui WangCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China Division of Infectious Diseases, State Key Laboratory of Biotherapy, Chengdu, China.
Xiaoxia ZhangCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China Division of Infectious Diseases, State Key Laboratory of Biotherapy, Chengdu, China.
Xinchuan ChenDepartment of Haematology, West China Hospital, Sichuan University, Chengdu, China.
Zhiyong ZongCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China Division of Infectious Diseases, State Key Laboratory of Biotherapy, Chengdu, China Department of Infection Control, West China Hospital, Sichuan University, Chengdu, China zongzhiy@scu.edu.cn.
Sichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the first OXA-181-producing strain in China. blaOXA-181 was found in sequence type 410 (ST410) Escherichia coli strain WCHEC14828 from a Chinese patient without recent travel history. Genome sequencing and conjugation experiments were performed. blaOXA-181 was carried on a 51-kb self-transmissible IncX3 plasmid and was linked with qnrS1, a quinolone resistance gene. blaOXA-181 was introduced onto the IncX3 plasmid from a ColE2-type plasmid, and IncX3 plasmids have the potential to mediate the dissemination of blaOXA-181.

Indexed as

Anti-Bacterial AgentsBase Sequencebeta-Lactamasesbeta-Lactam Resistancebeta-LactamsChinaConjugation, GeneticDNA, BacterialDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsEscherichia coli ProteinsHumansMicrobial Sensitivity TestsMolecular Sequence DataPlasmidsAnti-Bacterial Agentsbeta-lactamase OXA-181, E colibeta-Lactamasesbeta-LactamsDNA, BacterialEscherichia coli Proteins

Identifiers

PMID26014927
PMCPMC4505247
OpenAlexW1865009538

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.